Skip to search formSkip to main contentSkip to account menu

CGP 11305A

Known as: CGP-11305A 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

brofaromine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Results of an open clinical trial of brofaromine (CGP 11 305 A), a competitive, selective, and short-acting inhibitor of MAO-A in major endogenous depression.
In an open clinical trial the authors treated 18 hospitalized patients suffering from endogenous depression with brofaromine (CGP… 
Review
1986
Review
1986
New pharmacological developments in antidepressants.
The new pharmacological developments in antidepressants are reviewed with particular reference to MAOIs. Combining an MAOI with… 
1983
1983
Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain
SummaryCGP 11305A [4-(5-methoxy-7-bromo-benzofuranyl-2-)piperidine HCl], a reversible, selective inhibitor of MAO A, increased… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)